[
    {
        "id": "osp-10075",
        "type": "article-journal",
        "title": "Trichodysplasia Spinulosa",
        "author": [
            {
                "family": "Al Khalili",
                "given": "Ayida"
            },
            {
                "family": "Maciagowski",
                "given": "Elsa"
            },
            {
                "family": "Nguyen",
                "given": "Khue"
            },
            {
                "family": "Watters",
                "given": "Kevin A."
            }
        ],
        "URL": "https://omanscience.com/ar/articles/trichodysplasia-spinulosa",
        "language": "en",
        "issued": {
            "date-parts": [
                [
                    2025
                ]
            ]
        },
        "container-title": "Sultan Qaboos University Medical Journal",
        "volume": "24",
        "issue": "1",
        "page": "131-134",
        "DOI": "10.18295/squmj.5.2023.035",
        "publisher": "Sultan Qaboos University",
        "ISSN": "2075-051X",
        "abstract": "Trichodysplasia spinulosa (TS) is a unique, rare clinical and histological dermatologic entity described mainly in a setting of immunosuppression. It is caused by a novel human polymoavirus, TS-associated polyomavirus. Reduction of immunosuppression and/or anti-viral therapy is the main therapeutic strategies used to treat such cases. We report a biopsy-proven case of TS in a male renal transplant patient who presented to a dermatology outpatient clinic in Montreal, Canada, in 2015. He was managed with valgancyclovir with no obvious response. Subsequently, a trial of topical imiquimod was commenced. Awareness of TS can prompt early diagnosis and management to prevent possible complications.\n\nKeywords: Immunosuppression; Organ Transplant; Human Polyomavirus; Case Report; Canada."
    }
]